Geode Capital Management, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,190,932 shares of CRNX stock, worth $66.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,190,932
Previous 2,098,841
4.39%
Holding current value
$66.1 Million
Previous $107 Million
31.52%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding CRNX
# of Institutions
235Shares Held
87MCall Options Held
40KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA9.31MShares$281 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.89MShares$208 Million0.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.24MShares$188 Million2.28% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$188 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.11MShares$154 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.62B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...